|
Name |
2-Hydroxy-1-(1H-indol-3-yl)ethanone
|
Molecular Formula | C10H9NO2 | |
IUPAC Name* |
2-hydroxy-1-(1H-indol-3-yl)ethanone
|
|
SMILES |
C1=CC=C2C(=C1)C(=CN2)C(=O)CO
|
|
InChI |
InChI=1S/C10H9NO2/c12-6-10(13)8-5-11-9-4-2-1-3-7(8)9/h1-5,11-12H,6H2
|
|
InChIKey |
IBLZDDPFMAFWKP-UHFFFAOYSA-N
|
|
Synonyms |
2-Hydroxy-1-(1H-indol-3-yl)ethanone; 2400-51-3; 3-Glyceroindole; 2-Hydroxy-1-(3-indolyl)ethanone; Ethanone, 2-hydroxy-1-(1H-indol-3-yl)-; INDOLE-3-KETOL; Hydroxymethyl indol-3-yl ketone; 2-hydroxy-1-(1H-indol-3-yl)ethan-1-one; MFCD00466496; 2-hydroxy-1-(1H-indol-3-yl)-ethanone; BRN 0142060; 3-(Hydroxyacetyl)-1H-indole; 3-hydroxyacetylindole; 3-(Hydroxyacetyl)Indole; 3-(hydroxyacetyl)-indole; ChemDiv3_003333; 3-(hydroxylacetyl)-indole; Cambridge id 5106709; Oprea1_735053; MLS001049127; CHEMBL524903; SCHEMBL4056357; DTXSID80178731; CHEBI:173472; HMS1482H11; ZINC192311; 2-hydroxy-1-(indol-3-yl)ethanone; CAA40051; AC5698; STK386423; AKOS005431093; Hydroxymethyl indol-3-yl ketone, 8CI; IDI1_021243; NCGC00182562-01; BS-36792; SMR000386954; SY131003; CS-0450037; 2-Hydroxy-1-(1H-indol-3-yl)ethanone, 9CI
|
|
CAS | 2400-51-3 | |
PubChem CID | 200631 | |
ChEMBL ID | CHEMBL524903 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 175.18 | ALogp: | 1.4 |
HBD: | 2 | HBA: | 2 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 53.1 | Aromatic Rings: | 2 |
Heavy Atoms: | 13 | QED Weighted: | 0.684 |
Caco-2 Permeability: | -4.528 | MDCK Permeability: | 0.00000773 |
Pgp-inhibitor: | 0.001 | Pgp-substrate: | 0.003 |
Human Intestinal Absorption (HIA): | 0.019 | 20% Bioavailability (F20%): | 0.006 |
30% Bioavailability (F30%): | 0.957 |
Blood-Brain-Barrier Penetration (BBB): | 0.963 | Plasma Protein Binding (PPB): | 32.14% |
Volume Distribution (VD): | 1.301 | Fu: | 62.16% |
CYP1A2-inhibitor: | 0.895 | CYP1A2-substrate: | 0.192 |
CYP2C19-inhibitor: | 0.208 | CYP2C19-substrate: | 0.107 |
CYP2C9-inhibitor: | 0.053 | CYP2C9-substrate: | 0.632 |
CYP2D6-inhibitor: | 0.198 | CYP2D6-substrate: | 0.625 |
CYP3A4-inhibitor: | 0.096 | CYP3A4-substrate: | 0.187 |
Clearance (CL): | 6.416 | Half-life (T1/2): | 0.919 |
hERG Blockers: | 0.036 | Human Hepatotoxicity (H-HT): | 0.176 |
Drug-inuced Liver Injury (DILI): | 0.873 | AMES Toxicity: | 0.356 |
Rat Oral Acute Toxicity: | 0.948 | Maximum Recommended Daily Dose: | 0.335 |
Skin Sensitization: | 0.762 | Carcinogencity: | 0.152 |
Eye Corrosion: | 0.085 | Eye Irritation: | 0.989 |
Respiratory Toxicity: | 0.856 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC005757 | 0.732 | D05EJG | 0.549 | ||||
ENC001345 | 0.644 | D0K0KH | 0.420 | ||||
ENC004871 | 0.640 | D00YLW | 0.372 | ||||
ENC000043 | 0.609 | D07HBX | 0.362 | ||||
ENC001448 | 0.583 | D0W7WC | 0.337 | ||||
ENC000363 | 0.565 | D05OIS | 0.333 | ||||
ENC000140 | 0.549 | D0R1CR | 0.321 | ||||
ENC004706 | 0.549 | D0X9RY | 0.319 | ||||
ENC000341 | 0.533 | D0F5ZM | 0.317 | ||||
ENC000042 | 0.532 | D0GY5Z | 0.309 |